Arthritis Trial Finder

Search Results

28mm Ceramic-on-Ceramic Total Hip Replacement Study

Study Purpose

This study is intended to gather medium (0-5 years) and long-term (6-10 years) information regarding the performance and safety of the commercially available Ceramax™ Ceramic on Ceramic Total Hip System. This is a two-phased study consisting of a clinical follow-up phase and a clinical outcomes phase. In Phase One (0-5 years), diagnostic, demographic and operative information will be gathered for each subject enrolled in this study. In addition, Harris Hip Evaluations, subjective evaluations and radiographs will be completed annually. In Phase Two (6

  • - 10 years), a subjective outcomes questionnaire and a SF-12 Health Survey will be mailed to subjects annually.

Recruitment Criteria

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Accepts Healthy Volunteers 		Yes

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Study Type 		Interventional
Eligible Ages N/A and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Subjects who were previously enrolled in the COC28 IDE study, or - Newly recruited individuals who are qualified based on the approved labeling of the device, and; - Individuals who are willing and able to provide informed patient consent for participation in the study; - Individuals who are willing and able to return for follow-up as specified by the study protocol; and - Individuals who are willing and able to complete the Hip Outcomes questionnaire and SF-12 Health Survey as specified by the study protocol

    Exclusion Criteria:

    - In the opinion of the Investigator, the individual does not qualify based upon approved labeling requirements.

Trial Details

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

Trial ID: 		NCT01657435

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 		N/A

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Lead Sponsor 		DePuy Orthopaedics

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator 		Tammy L ODell, BS CCRC CCRA
Principal Investigator Affiliation DePuy Orthopaedics

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Agency Class 		Industry
Overall Status Recruiting
Countries Canada, United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Conditions 		Non-inflammatory Degenerative Joint Disease, Osteoarthritis, Avascular Necrosis, Post-traumatic Arthritis
Additional Details

This is a prospective, non-randomized study of the 28mm Ceramic on Ceramic (COC) device. This study will follow each subject through 10 years postoperatively and will consist of: 1. a clinical follow-up phase and 2. a clinical outcomes phase. Radiographic and clinical follow-up exams will take place at six-weeks, six-months and then annually through year 5 for each subject. For years 6

  • - 10, a communication will be sent to each subject in order to collect survivorship and general health information.
This communication will ask whether the COC device is still in vivo and, if not, when the revision surgery took place, why, and which components were removed, if applicable. In addition, subjects will be asked to complete a SF-12 Health Survey at each 6 to 10-year follow-up interval. A self-addressed, stamped envelope will be provided to facilitate information return and privacy.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Sacramento, California

Status

Completed

Address

Sacramento, California,

Colorado Joint Replacement, Denver, Colorado

Status

Active, not recruiting

Address

Colorado Joint Replacement

Denver, Colorado, 80210

Fort Collins, Colorado

Status

Withdrawn

Address

Fort Collins, Colorado,

Gainesville, Florida

Status

Not yet recruiting

Address

Gainesville, Florida,

Tampa, Florida

Status

Active, not recruiting

Address

Tampa, Florida,

Boston, Massachusetts

Status

Recruiting

Address

Boston, Massachusetts, 02120

Boston, Massachusetts

Status

Active, not recruiting

Address

Boston, Massachusetts,

Durham, North Carolina

Status

Active, not recruiting

Address

Durham, North Carolina,

Winston-Salem, North Carolina

Status

Completed

Address

Winston-Salem, North Carolina,

Columbus, Ohio

Status

Completed

Address

Columbus, Ohio,

Philadelphia, Pennsylvania

Status

Recruiting

Address

Philadelphia, Pennsylvania, 19104

Philadelphia, Pennsylvania

Status

Withdrawn

Address

Philadelphia, Pennsylvania, 19148

Alexandria, Virginia

Status

Completed

Address

Alexandria, Virginia,

International Sites

Montreal, Quebec, Canada

Status

Withdrawn

Address

Montreal, Quebec, H3T 1E2

Powered By

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.